Citigroup
RXST icon

Citigroup’s RxSight RXST Stock Holding History

Citigroup’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.7K Buy
18,398
+16,349
+798% +$98.7K ﹤0.01% 4752
2026
Q1 		$12.6K Buy
2,049
+1,156
+129% +$9.6K ﹤0.01% 4958
2025
Q4 		$9.3K Sell
893
-19,896
-96% -$200K ﹤0.01% 5084
2025
Q3 		$187K Buy
20,789
+5,274
+34% +$46.3K ﹤0.01% 4016
2025
Q2 		$202K Sell
15,515
-12,641
-45% -$190K ﹤0.01% 4059
2025
Q1 		$711K Sell
28,156
-35,439
-56% -$1.05M ﹤0.01% 3481
2024
Q4 		$2.19M Buy
63,595
+36,754
+137% +$1.66M ﹤0.01% 2744
2024
Q3 		$1.33M Buy
26,841
+2,351
+10% +$120K ﹤0.01% 3027
2024
Q2 		$1.47M Buy
24,490
+8,353
+52% +$477K ﹤0.01% 2596
2024
Q1 		$832K Buy
16,137
+1,719
+12% +$84.4K ﹤0.01% 3174
2023
Q4 		$581K Buy
14,418
+14,356
+23,155% +$421K ﹤0.01% 3293
2023
Q3 		$1.73K Sell
62
-20,053
-100% -$598K ﹤0.01% 5002
2023
Q2 		$579K Buy
20,115
+20,103
+167,525% +$447K ﹤0.01% 3267
2023
Q1 		$200 Sell
12
-127
-91% -$1.79K ﹤0.01% 5256
2022
Q4 		$1.76K Sell
139
-172
-55% -$2.09K ﹤0.01% 5280
2022
Q3 		$4K Sell
311
-1,018
-77% -$14K ﹤0.01% 5325
2022
Q2 		$19K Buy
1,329
+676
+104% +$8.92K ﹤0.01% 5040
2022
Q1 		$8K Sell
653
-1,422
-69% -$17.1K ﹤0.01% 5641
2021
Q4 		$23K Buy
2,075
+1,127
+119% +$13.5K ﹤0.01% 5349
2021
Q3 		$12K Buy
+948
New +$13K ﹤0.01% 5425

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup's RXST Position: Q2 2026 in Review

Citigroup increased its RxSight (RXST) stake by 798% in Q2 2026, buying an estimated $98.7K and bringing the position to 18,398 shares worth $88.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4752.

Citigroup first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.19M in Q4 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Citigroup held 18,398 shares of RxSight worth $88.7K as of Q2 2026.
  • Citigroup bought 16,349 RxSight shares in Q2 2026, an estimated $98.7K.
  • RxSight made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4752 holding.
  • Citigroup first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Citigroup's RxSight position peaked at $2.19M in Q4 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.